Filter
511
Text search:
leprosy
programmes
Featured
Recommendations
72
New Publications
172
Language
Document type
No document type
353
Studies & Reports
51
Guidelines
48
Strategic & Response Plan
28
Manuals
22
Training Material
4
Fact sheets
3
Situation Updates
1
Resource Platforms
1
Countries / Regions
India
49
Kenya
24
Tanzania
23
Sierra Leone
19
Nepal
19
Nigeria
16
Uganda
16
Namibia
15
Bangladesh
14
Global
14
Myanmar / Burma
13
Liberia
11
Zambia
10
Ethiopia
9
Cambodia
8
Rwanda
5
Indonesia
5
Malawi
5
Africa
5
Ghana
4
Zimbabwe
4
Pakistan
4
Lesotho
4
Guinea
3
Congo, Democratic Republic of
3
Mozambique
3
Sudan
3
Cameroon
2
South Sudan
2
Jordan
2
South Africa
2
Botswana
2
South–East Asia Region
2
Mali
1
Morocco
1
Saudi Arabia
1
Haiti
1
Philippines
1
Somalia
1
Iraq
1
Afghanistan
1
Lebanon
1
Syria
1
Gambia
1
Papua New Guinea
1
Brazil
1
Greece
1
Madagascar
1
Sri Lanka
1
Middle East and North Africa
1
Western Pacific Region
1
Latin America and the Carribbean
1
Western and Central Europe
1
Paraguay
1
Asia
1
Bhutan
1
Albania
1
Southern Africa
1
Timor Leste/ East Timor
1
Iran
1
Georgia
1
Vietnam
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
252
Clinical Guidelines
45
Public Health
37
Key Resources
13
Women & Child Health
10
Capacity Building
9
Pharmacy & Technologies
8
Toolboxes
NTDs
86
TB
85
Disability
55
AMR
16
HIV
12
Pharmacy
8
Ebola & Marburg
7
Rapid Response
7
NCDs
5
2.0 Rapid Response
4
Polio
3
Mental Health
3
COVID-19
3
Caregiver
3
Health Financing Toolbox
3
Cholera
2
Natural Hazards
2
Global Health Education
2
Planetary Health
2
Conflict
1
Refugee
1
Specific Hazards
1
Social Ethics
1
Malaria
1
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf
...
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual ev
...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
...
ILEP Technical Guide
Meeting the rehabilitation needs of people affected by leprosy and promoting quality of life.
How to Recognise and Manage Leprosy Reactions
recommended
This book is for all health workers who may have to help people who have nerve damage to their eyes, hands and feet. It will help them to encourage patients to develop a lifetime habit of caring for nerve-damaged parts.
Leprosy will be eliminated when we detect all patients and cure them by using multidrug therapy (MDT).
Elimination means bringing the disease burden down to a very low level. This will lead to a reduction in the source of infection, so that
...
This booklet is recommended for all health workers who diagnose and treat leprosy, especially those at the first referral level such as a health centre. It contains more detail than the WHO Guide to Eliminate
...
Apart from implementation of TB infection Prevention and Control measures, treatment of those with active TB of the lungs is key in preventing the spread of the TB bacilli. The Public Health Act CAP 242, section 17 classify TB as notifiable infectious disease and under section 26 as part of preventi
...
Malawi is a landlocked country with a surface area of 118,484 km2. Administratively, the country is divided into three regions, namely the Northern, Central and Southern regions. The country has 28 districts, which are further divided into traditional authorities (TA) ruled by chiefs. The TAs are su
...
2nd edition.
Like the original, this second edition of the guidance aims to inform the revision of existing national guidelines and standards for managing Tuberculosis (TB), many of which include guidance on children. It includes recommendations, based on the best available evidence, for improving
...
This is an update of a seven-year TB and Leprosy national strategic plan (TBL-NSP), which extends from 2013 to 2020. The update focuses on the plan covering from 2017-20 and is based on the 2017 external mid-term programme review key findings and re
...
